Evaluation of Viral and Bacterial Pathogens in the Central Nervous System Infections with Multiplex PCR

J Coll Physicians Surg Pak. 2022 Dec;32(12):1605-1608. doi: 10.29271/jcpsp.2022.12.1605.

Abstract

Objective: To evaluate the bacterial and viral causes of central nervous system (CNS) infection by multiplex PCR.

Study design: Descriptive study.

Place and duration of study: Department of Medical Microbiology, Pamukkale University Faculty of Medicine, Turkey, from March 2016 to December 2021.

Methodology: Cerebrospinal fluid (CSF) samples of patients prediagnosed with CNS infection were included in the study. Viral pathogens were detected with the Multiplex real-time PCR panel (FTD Neuro9, Fast Track Diagnostics, Luxembourg) and bacterial pathogens with the multiplex real-time PCR panel (FTD Bacterial Meningitis, Fast Track Diagnostics, Luxembourg). The identification of bacteria growing in samples was done by conventional methods and with the Phoenix™ (Becton Dickinson Diagnostics, USA) automated system.

Results: CSF samples of 440 patients were evaluated using multiplex PCR panel. The viral factors included adenovirus (14.2%), human herpes virus 7 (1.5%), varicella zoster virus (1.3%), herpes simplex virus 1 (1.3%), cytomegalovirus (1.3%), Epstein-Barr virus (0.8%), human herpes virus (0.8%), herpes simplex virus 2 (0.3%), varicella zoster virus (0.3%), and parvovirus B19 (0.3%); and bacterial factors included Streptococcus pneumoniae (7.0%) and Neisseria meningitidis (0.9%). The bacterial growth was detected in the CSF culture was 4.9%. Among the growing bacteria, there were six different types that were not found on the multiplex PCR panel.

Conclusion: The use of a comprehensive bacterial multiplex PCR panel containing common pathogens will be more effective in pathogen detection. Care should be taken, especially when interpreting the viral Multiplex PCR.

Key words: Viral multiplex PCR, Bacterial multiplex PCR, Bacteria culture.

MeSH terms

  • Bacteria / genetics
  • Central Nervous System Infections* / diagnosis
  • Epstein-Barr Virus Infections*
  • Herpesvirus 4, Human
  • Humans
  • Turkey